Azithromycin-Propylaxe ist besonders wirksam

Akute Exazerbationen bei schwerer COPD

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Vestbo J et al: Am J Respir Crit Care Med 2012; 187:347–65.
Article PubMed Google Scholar
Wedzicha JA, Seemugal TA: Lancet 2007; 370:786–96.
Article PubMed Google Scholar
Herath SC, Poole P: Cochrane Database Syst Rev 2013; 11:CD009764.
PubMed Google Scholar
Albert RK et al: N Engl J Med 2011; 365:689–98.
Article PubMed CAS PubMed Central Google Scholar
Restrepo MI, Anzueto A: Am J Respir Crit Care Med 2014; 190: 1–2.
Article PubMed Google Scholar
Hodge S, Reynolds PN: Respirology 2012; 17:802–7.
Article PubMed Google Scholar
Ray WA et al: N Engl J Med 2012; 366:1881–90.
Article PubMed CAS PubMed Central Google Scholar

Han MK, Tayob N, Murray S et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med 2014;189(12):1503–8.
Article PubMed CAS Google Scholar

Authors

Kurt Rasche
View author publications
You can also search for this author in PubMed Google Scholar

Rasche, K. Azithromycin-Propylaxe ist besonders wirksam. Pneumo News 6, 30 (2014). https://doi.org/10.1007/s15033-014-0024-4

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.